CRISPR/Cas9 screen identifies KRAS-induced COX-2 as a driver of immunotherapy resistance in lung cancer

Jesse Boumelha(The Francis Crick Institute), Julian Downward(The Francis Crick Institute)
bioRxiv (Cold Spring Harbor Laboratory)
April 14, 2023
Cited by 2


Related Papers